S3188Referred to Committee

Biomanufacturing Excellence Act of 2025

Share:
Introduced
In Committee
3
Passed One Chamber
4
Passed Both
5
Signed into Law
119th
Congress
2025-11-18
Introduced
5
Cosponsors
S
ⓘ
Type

Sponsor

Christopher A. Coons
Christopher A. Coons
Democrat · DE · Senator
Votes with party: 80.6% (814 recorded votes)

Full profile: /officials/C001088

Source: Congress.gov · FEC

Cosponsors (5)

Members who have signed on to support this bill since introduction. Source: Congress.gov.

Latest Action

The most recent step in the bill's legislative path. Committee Activity below shows referrals and reports; the full action-by-action history including floor proceedings lives at Congress.gov →

Read twice and referred to the Committee on Commerce, Science, and Transportation.

2025-11-18

Source: Congress.gov

Committee Activity

Previously

Plain-English Summary

This bill aims to strengthen the U.S. biomanufacturing industry—the production of medicines, vaccines, and biological products—by investing in research, workforce training, and manufacturing facilities. It would help American companies compete globally in biotechnology while reducing dependence on other countries for critical medicines and vaccines. The legislation affects pharmaceutical companies, research institutions, workers entering the biotech field, and patients who depend on these medicines.

AI-assisted summary generated from the official bill metadata (title, subjects, actions) sourced from Congress.gov. Cached and reviewed. Always verify against the official text linked below.

Subjects

Science, Technology, Communications
Full bill text is not yet cached locally.
Open text viewRead on Congress.gov

Related legislation

Bills by the same sponsor or covering overlapping subjects.